Dunbar, G. L., Koneru, S., Kolli, N., Sandstrom, M., Maiti, P., & Rossignol, J. (2019). Silencing of the Mutant Huntingtin Gene through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease. Cell Transplant.
Chicago Style CitationDunbar, Gary L., Sindhuja Koneru, Nivya Kolli, Michael Sandstrom, Panchanan Maiti, i Julien Rossignol. "Silencing of the Mutant Huntingtin Gene Through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease." Cell Transplant 2019.
Cita MLADunbar, Gary L., et al. "Silencing of the Mutant Huntingtin Gene Through CRISPR-Cas9 Improves the Mitochondrial Biomarkers in an In Vitro Model of Huntington’s Disease." Cell Transplant 2019.